Christos Dimosthenous

11PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursRespiratory diseasesCardiology (incl. cardiovascular diseases)Chemical thermodynamics and energetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 12, 2026
Longitudinal Cognitive Assessment After CAR-T Cell Immunotherapy: A Prospective Cohort Study.

|Nov 27, 2025
Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid Malignancies.

Eleni Gavriilaki, Panagiotis Dolgyras, Ioannis Konstantinidis

|Sep 13, 2025
Endothelial Injury Following CAR-T Cell Immunotherapy for Hematological Malignancies.

Christos Demosthenous, Paschalis Evangelidis, Athanasios Gatsis

|Aug 25, 2025
Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial.

Thomas Chatzikonstantinou, Maria Vasilopoulou, Dimitrios Kyrou

|Jul 29, 2025
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study.

Ioulia Mavrikou, Marta Castelli, Tasoula Touloumenidou

|Oct 26, 2024
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients.

Eleni Gavriilaki, Christos Demosthenous, Paschalis Evangelidis

Pageof 2

Frequent Collaborators

7 joint publications

Eleni Gavriilaki

4 joint publications

Paschalis Evangelidis

4 joint publications

Zoi Bousiou

3 joint publications

Panagiotis Dolgyras